Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Equity Ratio (2016 - 2025)

Collegium Pharmaceutical has reported Equity Ratio over the past 10 years, most recently at 0.18 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.18 for Q4 2025, up 32.36% from a year ago — trailing twelve months through Dec 2025 was 0.18 (up 32.36% YoY), and the annual figure for FY2025 was 0.18, up 32.36%.
  • Equity Ratio for Q4 2025 was 0.18 at Collegium Pharmaceutical, up from 0.17 in the prior quarter.
  • Over the last five years, Equity Ratio for COLL hit a ceiling of 0.35 in Q2 2021 and a floor of 0.14 in Q4 2024.
  • Median Equity Ratio over the past 5 years was 0.17 (2022), compared with a mean of 0.19.
  • Biggest five-year swings in Equity Ratio: soared 47.24% in 2021 and later crashed 55.25% in 2022.
  • Collegium Pharmaceutical's Equity Ratio stood at 0.29 in 2021, then crashed by 43.4% to 0.17 in 2022, then increased by 3.01% to 0.17 in 2023, then fell by 19.53% to 0.14 in 2024, then skyrocketed by 32.36% to 0.18 in 2025.
  • The last three reported values for Equity Ratio were 0.18 (Q4 2025), 0.17 (Q3 2025), and 0.15 (Q2 2025) per Business Quant data.